What is Exagen Inc.'s operating cash flow?

Exagen Inc. (XGN) reported operating cash flow of -$10.42M in Q1 2026.

How has Exagen Inc.'s operating cash flow changed year-over-year?

Exagen Inc.'s operating cash flow increased by 2.4% year-over-year, from -$10.67M to -$10.42M.

What is the long-term trend for Exagen Inc.'s operating cash flow?

Over 2 years (2021 to 2024), Exagen Inc.'s operating cash flow has grown at a -18.0% compound annual growth rate (CAGR), from -$20.27M to -$13.64M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Exagen Inc. XGN Operating Cash Flow

Operating Cash Flow at other companies

Labcorp HoldingsLH

$191.5M+935%

Quest DiagnosticsDGX

$278M-11.5%

Vor BiopharmaVOR

-$38.25M-23.1%

Avalo TherapeuticsAVTX

-$17.69M-87.1%

CareDxCDNA

$4.33M+116%

Bio-Rad LaboratoriesBIO

$108.1M-16.8%

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s operating cash flow?: Exagen Inc. (XGN) reported operating cash flow of -$10.42M in Q1 2026.
How has Exagen Inc.'s operating cash flow changed year-over-year?: Exagen Inc.'s operating cash flow increased by 2.4% year-over-year, from -$10.67M to -$10.42M.
What is the long-term trend for Exagen Inc.'s operating cash flow?: Over 2 years (2021 to 2024), Exagen Inc.'s operating cash flow has grown at a -18.0% compound annual growth rate (CAGR), from -$20.27M to -$13.64M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.